United States Government Publishing Office
publisher
pbl
distributor
dst
United States
National Archives and Records Administration
Office of the Federal Register
author
aut
Government Organization
text
government publication
eng
FR
Regulatory Information
2020_register
executive
2020-10-22
article
Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Additional Criteria and Procedures for Classifying Over-the-Counter Drugs as Generally Recognized as Safe and Effective and Not Misbranded-Time and Extent Applications for Nonprescription Drug Products
Notices
D09002ee1c1021c43
D09002ee1c1021cbe
United States
Department of Health and Human Services
originator
org
United States Government Agency or Subagency
United States
Food and Drug Administration
originator
org
United States Government Agency or Subagency
The Food and Drug Administration (FDA) is announcing that a proposed collection of information has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995.
85 FR 67352
https://www.govinfo.gov/app/details/FR-2020-10-22/2020-23357
2020-23357
fr22oc20-54
4164-01-P
Docket No. FDA-2010-N-0493
https://www.govinfo.gov/app/details/FR-2020-10-22/2020-23357
https://www.govinfo.gov/content/pkg/FR-2020-10-22/html/2020-23357.htm
https://www.govinfo.gov/content/pkg/FR-2020-10-22/pdf/2020-23357.pdf
2 p.
67352
67353
85 FR 67352
Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Additional Criteria and Procedures for Classifying Over-the-Counter Drugs as Generally Recognized as Safe and Effective and Not Misbranded-Time and Extent Applications for Nonprescription Drug Products; Federal Register Vol. 85, Issue
NOTICE
2020-23357
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
2020-11-23
Docket No. FDA-2010-N-0493
4164-01-P
2020-23357
Notice.
The Food and Drug Administration (FDA) is announcing that a proposed collection of information has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995.
Submit written comments (including recommendations) on the collection of information by November 23, 2020.
Domini Bean, Office of Operations, Food and Drug Administration, Three White Flint North, 10A-12M, 11601 Landsdown St., North Bethesda, MD 20852, 301-796-5733, PRAStaff@fda.hhs.gov.
Agency Information Collection Activities; Proposals, Submissions, and Approvals:
Additional Criteria and Procedures for Classifying Over-the-Counter Drugs as Generally Recognized as Safe and Effective and Not MisbrandedTime and Extent Applications for Nonprescription Drug Products,
PRAStaff@fda.hhs.gov
https://www.fda.gov/regulatory-information/search-fda-guidance-documents/time-and-extent-applications-nonprescription-drug-products
https://www.reginfo.gov/public/do/PRAMain
Federal Register
Vol. 85, no. 205
Office of the Federal Register, National Archives and Records Administration
2020-10-22
continuing
daily
deposited
born digital
177 p.
Table of Contents:
AE 2.7:
GS 4.107:
AE 2.106:
KF70.A2
https://www.govinfo.gov/app/details/FR-2020-10-22
P0b002ee1a91002f6
0097-6326
0042-1219
0364-1406
769-004-00000-9
000582072
f:fr22oc20
https://www.govinfo.gov/app/details/FR-2020-10-22
https://www.govinfo.gov/content/pkg/FR-2020-10-22/pdf/FR-2020-10-22.pdf
https://www.govinfo.gov/content/pkg/FR-2020-10-22/xml/FR-2020-10-22.xml
fdlp
67261
67426
DGPO
2020-10-22
2023-09-26
FR-2020-10-22
machine generated
eng
FR
FR-2020-10-22
85
205